Lorazepam Intensol

Commonly reported side effects of lorazepam include: sedated state. Other side effects include: dizziness. See below for a comprehensive list of adverse effects.

Applies to lorazepam: oral solution, oral tablet

Other dosage forms:

• injection solution

Along with its needed effects, lorazepam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking lorazepam:

More common

• Drowsiness
• relaxed and calm
• sleepiness

Incidence not known

• Abdominal or stomach pain
• aggressive, angry
• agitation
• attack, assault, or force
• black, tarry stools
• bleeding gums
• blood in the urine or stools
• bluish lips or skin
• blurred vision
• change in consciousness
• chills
• coma
• confusion
• confusion about identity, place, and time
• convulsions
• cough or hoarseness
• dark urine
• decreased urine output
• difficulty with breathing or swallowing
• difficulty with speaking
• discouragement
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• drooling
• dry mouth
• excitation
• false or unusual sense of well-being
• fast or irregular heartbeat
• feeling sad or empty
• fever with or without chills
• general feeling of tiredness or weakness
• headache
• hives, itching, or rash
• hyperventilation
• increased thirst
• irregular, fast or slow, or shallow breathing
• irritability
• loss of appetite
• loss of balance control
• loss of consciousness
• loss of interest or pleasure
• loss of memory
• lower back or side pain
• muscle pain or cramps
• muscle trembling, jerking, or stiffness
• nausea or vomiting
• not breathing
• painful or difficult urination
• pale or blue lips, fingernails, or skin
• pinpoint red spots on the skin
• problems with memory
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• reddening of the skin, especially around ears
• restlessness
• seeing, hearing, or feeling things that are not there
• seizures
• shaking
• shuffling walk
• sore throat
• sores, ulcers, or white spots on the lips or in the mouth
• stiffness of the limbs
• sweating
• swelling of the eyes or inside of the nose
• swelling of the face, ankles, or hands
• swollen glands
• thoughts or attempts at killing oneself
• tightness in the chest
• trouble concentrating
• trouble sleeping
• twisting movements of body
• uncontrolled movements, especially of the face, neck, and back
• unexplained bleeding or bruising
• unpleasant breath odor
• unusual bleeding or bruising
• unusual tiredness or weakness
• vomiting of blood
• yellow eyes or skin

Get emergency help immediately if any of the following symptoms of overdose occur while taking lorazepam:

Symptoms of overdose

• Changes in patterns and rhythms of speech
• increased sweating
• loss of strength or energy
• nightmares
• shakiness and unsteady walk
• slurred speech
• trouble speaking
• unsteadiness, trembling, or other problems with muscle control or coordination
• unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
• unusual excitement, nervousness, restlessness, or irritability
• unusual paleness
• unusual weak feeling

Some side effects of lorazepam may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

• Being forgetful
• clumsiness
• constipation
• decreased interest in sexual intercourse
• disturbed color perception
• dizziness or lightheadedness
• double vision
• drowsiness
• feeling of constant movement of self or surroundings
• hair loss or thinning of the hair
• halos around lights
• inability to have or keep an erection
• increased in sexual ability, desire, drive, or performance
• increased interest in sexual intercourse
• lack or loss of self-control
• lethargy
• loss in sexual ability, desire, drive, or performance
• muscle aches, twitching, or weakness
• night blindness
• overbright appearance of lights
• rapid weight gain
• sensation of spinning
• shakiness in the legs, arms, hands, or feet
• shivering
• stupor
• trembling or shaking of the hands or feet
• tunnel vision
• weak or feeble pulse

Applies to lorazepam: compounding powder, injectable solution, intravenous solution, oral concentrate, oral tablet

Oral: The most commonly reported side effects included sedation, dizziness, weakness, and unsteadiness.

Parenteral: The most commonly reported side effects included somnolence, respiratory failure, hypotension, and injection site reactions (pain and burning).

Parenteral:

Very common (10% or more): Burning (up to 17%), pain (up to 17%)

Common (1% to 10%): Painful response, redness

Uncommon (0.1% to 1%): Injection site reaction

Frequency not reported: Arteriospasm, gangrene, injection site tolerance

Oral:

Very common (10% or more): Sedation (up to 15.9%)

Common (1% to 10%): Anterograde amnesia, ataxia, daytime drowsiness, dizziness, unsteadiness

Rare (0.01% to 0.1%): Dysarthria, headache, memory impairment, reduced alertness, slurred speech, transient anterograde amnesia

Very rare (less than 0.01%): Coma, extrapyramidal reactions, tremor

Frequency not reported: Amnesia, autonomic manifestations, convulsions/seizures, drowsiness, extremity numbness/tingling, hyperreflexia, hypersensitivity to light/noise/sound, involuntary movements, short-term memory loss, vertigo

Parenteral:

Common (1% to 10%): Coma, excessive drowsiness/sleepiness, headache, sedation, somnolence, stupor

Uncommon (0.1% to 1%): Brain edema, convulsion, myoclonus, tremor

Frequency not reported: Dizziness

Postmarketing reports: Amnesia, neuroleptic malignant syndrome, paralysis

Oral:

Common (1% to 10%): Asthenia, fatigue, weakness

Uncommon (0.1% to 1%): Chills

Very rare (less than 0.01%): Hypothermia

Frequency not reported: Hyperacusis, hyperthermia, paradoxical reactions, rebound phenomena

Parenteral:

Common (1% to 10%): Asthenia, crying, fatigue, sobbing

Frequency not reported: Depressed hearing, falls, hypothermia, paradoxical reactions, tinnitus

Postmarketing reports: Fatalities

Oral:

Rare (0.01% to 0.1%): Change in libido, confusion, decreased orgasm, depression, disinhibition, euphoria, numbed emotions, sleep disturbances, unmasking of depression

Frequency not reported: Aggression, aggressiveness, agitation, anxiety, catatonia, dependence, delirium, delusion, disorientation, drug withdrawal symptoms, excitation, hallucinations, hostility, impotence, inappropriate behavior, irritability, insomnia, nightmares, panic attacks, psychoses, rage, restlessness, sexual arousal, suicidal attempt/ideation, tension

Parenteral:

Common (1% to 10%): Confusion, delirium, depression, restlessness, unmasking of depression, visual hallucinations

Uncommon (0.1% to 1%): Abnormal thinking, agitation, ataxia, change in libido, decreased orgasm, hallucinations

Frequency not reported: Aggression, agitation, anxiety, disinhibition, excitation, euphoria, hostility, inappropriate behavior, insomnia, irritability, mania, psychosis, rage, sexual arousal, sleep disturbances, stimulation, suicidal attempt/ideation

Postmarketing reports: Acute brain syndrome, nervousness

Oral:

Rare (0.01% to 0.1%): Apnea, respiratory depression, worsening of obstructive pulmonary disease, worsening of sleep apnea

Parenteral:

Common (1% to 10%): Apnea, hypoventilation, respiratory disorder, respiratory failure

Uncommon (0.1% to 1%): Hyperventilation

Frequency not reported: Airway obstruction

Postmarketing reports: Lung edema, lung hemorrhage, pneumothorax, pulmonary hypertension, respiratory arrest

Oral:

Rare (0.01% to 0.1%): Hypotension

Frequency not reported: Palpitations, small decreases in blood pressure

Parenteral:

Common (1% to 10%): Hypotension

Postmarketing reports: Arrhythmia, bradycardia, heart arrest/failure, heart block, pericardial effusion, tachycardia, ventricular arrhythmia

Oral:

Frequency not reported: Muscle pain

Parenteral:

Common (1% to 10%): Muscle weakness

Oral:

Rare (0.01% to 0.1%): Constipation, nausea, salivation changes

Frequency not reported: Abdominal cramps, dry mouth, gastrointestinal symptoms, hypersalivation, vomiting

Parenteral:

Uncommon (0.1% to 1%): Increased salivation, nausea, vomiting

Frequency not reported: Constipation

Postmarketing reports: Gastrointestinal hemorrhage

Oral:

Rare (0.01% to 0.1%): Change in appetite, increase in alkaline phosphatase

Very rare (less than 0.01%): Hyponatremia

Frequency not reported: Loss of appetite

Parenteral:

Uncommon (0.1% to 1%): Acidosis, increased alkaline phosphatase

Frequency not reported: Hyponatremia

Oral:

Rare (0.01% to 0.1%): Allergic dermatitis, rash

Frequency not reported: Allergic skin reactions, alopecia, dermatological symptoms, sweating

Parenteral:

Uncommon (0.1% to 1%): Hypertension, hypotension

Frequency not reported: Allergic skin reactions, alopecia, skin rash

Oral:

Rare (0.01% to 0.1%): Abnormal liver function test values, increase in bilirubin, increase in liver transaminases, jaundice

Parenteral:

Uncommon (0.1% to 1%): Abnormal liver function tests

Postmarketing reports: Liver damage

Oral:

Rare (0.01% to 0.1%): Impotence

Parenteral:

Uncommon (0.1% to 1%): Impotence

Postmarketing reports: Urinary incontinence

Parenteral:

Uncommon (0.1% to 1%): infection

Parenteral:

Uncommon (0.1% to 1%): Cystitis

Oral:

Rare (0.01% to 0.1%): Blurred vision, diplopia, eye function/visual disturbance

Parenteral:

Frequency not reported: Blurred vision, diplopia

Oral:

Very rare (less than 0.01%): Agranulocytosis, leukopenia, pancytopenia, thrombocytopenia

Parenteral:

Frequency not reported: Agranulocytosis, hypochromic anemia, leukocytosis, pancytopenia, thrombocythemia, thrombocytopenia

Postmarketing reports: Coagulation disorder

Oral:

Very rare (less than 0.01%): Anaphylactoid reactions, anaphylaxis, hypersensitivity

Frequency not reported: Hypersensitivity reactions

Parenteral:

Frequency not reported: Anaphylactic reactions, anaphylactoid reactions, angioedema, hypersensitivity reactions

Oral:

Very rare (less than 0.01%): Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Parenteral:

Frequency not reported: Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Postmarketing reports: Aggravation of pheochromocytoma